• OncoCyte (NYSEAMERICAN:OCX) Upgraded at Zacks Investment Research

    Zacks Investment Research upgraded shares of OncoCyte (NYSEAMERICAN:OCX) from a hold rating to a buy rating in a report issued on Saturday …

    Read More
  • 0 0